title: Craniopharyngioma: presentation and endocrine sequelae in 36 children.
abstract: We studied the clinical presentation by age of 36 children with craniopharyngioma, and outcome by height and body mass index (BMI). Presenting symptoms included headache (51.4%), vomiting (31%), visual disturbances (22.9%), polyuria and/or polydipsia (17.1%), delayed puberty (19.4%), short stature (13.8%), and precocious puberty (2.7%). Growth deceleration was overlooked, as was diabetes insipidus (actual rate, 52% for both). Delayed puberty was observed in all patients of appropriate age. Mean height standard deviation score (SDS) at admission was significantly lower than mean target height SDS (p = 0.004), while mean final height SDS was similar (p = 0.14). BMI SDS at last follow-up was similar to mean parental BMI SDS. We conclude that although endocrinopathies are present in most patients with craniopharyngioma, they are rarely the reason for referral. While affected prepubertal children have non-endocrine complaints, most adolescents are referred because of delayed puberty. Diabetes insipidus may be more prevalent in craniopharyngioma than previously reported. When patients with hypothalamic obesity are excluded, mean BMI SDS remains within normal range and is influenced mostly by parental BMI SDS.
authors.affiliation: Institute for Endocrinology and Diabetes, Schneider Children's Medical Center of Israel, Petah Tiqva, Israel. liatd@clalit.org.il
authors.forename: L
authors.initials: L
authors.lastname: de Vries
authors.forename: L
authors.initials: L
authors.lastname: Lazar
authors.forename: M
authors.initials: M
authors.lastname: Phillip
mesh_terms: D000293:Adolescent; D000328:Adult; D001827:Body Height; D015992:Body Mass Index; D002648:Child; D002675:Child, Preschool; D003397:Craniopharyngioma / Q000150:complications* / Q000175:diagnosis* / Q000453:epidemiology / Q000601:surgery; D003919:Diabetes Insipidus / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000601:surgery; D004700:Endocrine System Diseases / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology* / Q000601:surgery; D005260:Female; D005500:Follow-Up Studies; D006130:Growth Disorders / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000601:surgery; D006801:Humans; D007223:Infant; D008297:Male; D015995:Prevalence; D011628:Puberty, Delayed / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000601:surgery; D011629:Puberty, Precocious / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000601:surgery; D012737:Sex Factors; D016896:Treatment Outcome